×
About 5,127 results

ALLMedicine™ Merkel Cell Carcinoma Center

Research & Reviews  2,389 results

The Impact of Adverse Events on Healthcare Resource Utilization, Costs, and Mortality a...
https://doi.org/10.1002/onco.13812
The Oncologist; George S, Bell EJ et. al.

May 6th, 2021 - We investigated the association between adverse events (AEs) suspected to be immune-related and healthcare resource utilization (HCRU), costs, and mortality among patients receiving PD-1/PD-L1 immune checkpoint inhibitor (ICI) monotherapy for urot...

International increases in Merkel cell carcinoma incidence rates between 1997 and 2016.
https://doi.org/10.1016/j.jid.2021.04.007
The Journal of Investigative Dermatology; Olsen CM, Pandeya N et. al.

May 1st, 2021 - Relatively little is known about the epidemiology of Merkel cell carcinoma (MCC) with regards to international trends in incidence, specifically relating to differences by age, sex and anatomic site. We examined trends in sex-specific incidence of...

Tumor-Infiltrating Lymphocytes Are Associated with Improved Survival in Node-Positive M...
https://doi.org/10.1016/j.jaad.2021.03.125
Journal of the American Academy of Dermatology; Copeland AR, Shindorf ML et. al.

May 1st, 2021 - Tumor-Infiltrating Lymphocytes Are Associated with Improved Survival in Node-Positive Merkel Cell Carcinoma: A National Cohort Analysis.|2021|Copeland AR,Shindorf ML,McDonald JD,Hernandez JM,Davis JL,|

ASO Author Reflections: False Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcin...
https://doi.org/10.1245/s10434-021-10056-4 10.1245/s10434-009-0858-x 10.1016/j.jaad.2019.12.072
Annals of Surgical Oncology; Straker RJ, Karakousis GC et. al.

Apr 29th, 2021 - ASO Author Reflections: False Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma.|2021|Straker RJ,Karakousis GC,Miura JT,|

see more →

Guidelines  5 results

Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2018.0055
Journal of the National Comprehensive Cancer Network : JN... Bichakjian CK, Olencki T et. al.

Jun 12th, 2018 - This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on areas impacted by recently emerging data, including sections describing MCC risk factors, diagnosis, workup, follow-up, and management of advanced disease with radi...

Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/16/6/742.full
Bichakjian, C.

May 31st, 2018 - This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on areas impacted by recently emerging data, including sections describing MCC risk factors, diagnosis, workup, follow-up, and management of advanced disease with radi.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdiscipl...
https://doi.org/10.1016/j.ejca.2015.06.131
European Journal of Cancer (Oxford, England : 1990); Lebbe C, Becker JC et. al.

Aug 10th, 2015 - Merkel cell carcinoma (MCC) is a rare tumour of the skin of neuro-endocrine origin probably developing from neuronal mechanoreceptors. A collaborative group of multidisciplinary experts form the European Dermatology Forum (EDF), The European Assoc...

Merkel cell carcinoma, version 1.2014.
https://doi.org/10.6004/jnccn.2014.0041
Journal of the National Comprehensive Cancer Network : JN... Bichakjian CK, Olencki T et. al.

Mar 12th, 2014 - Merkel cell carcinoma is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative nonmelanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The NCCN Guidelines for Merkel Cell Carc...

Guidelines for the diagnosis and treatment of Merkel cell carcinoma - Cutaneous Oncolog...
https://doi.org/10.1684/ejd.2012.1694
European Journal of Dermatology : EJD; Boccara O, Girard C et. al.

Apr 13th, 2012 - Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin. The epidemiological factors strongly associated with this tumor are: age over 65 years, fair skin, chronic sun exposure and immune suppression. Data are sparse in the literatu...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  2,553 results

The Impact of Adverse Events on Healthcare Resource Utilization, Costs, and Mortality a...
https://doi.org/10.1002/onco.13812
The Oncologist; George S, Bell EJ et. al.

May 6th, 2021 - We investigated the association between adverse events (AEs) suspected to be immune-related and healthcare resource utilization (HCRU), costs, and mortality among patients receiving PD-1/PD-L1 immune checkpoint inhibitor (ICI) monotherapy for urot...

International increases in Merkel cell carcinoma incidence rates between 1997 and 2016.
https://doi.org/10.1016/j.jid.2021.04.007
The Journal of Investigative Dermatology; Olsen CM, Pandeya N et. al.

May 1st, 2021 - Relatively little is known about the epidemiology of Merkel cell carcinoma (MCC) with regards to international trends in incidence, specifically relating to differences by age, sex and anatomic site. We examined trends in sex-specific incidence of...

Tumor-Infiltrating Lymphocytes Are Associated with Improved Survival in Node-Positive M...
https://doi.org/10.1016/j.jaad.2021.03.125
Journal of the American Academy of Dermatology; Copeland AR, Shindorf ML et. al.

May 1st, 2021 - Tumor-Infiltrating Lymphocytes Are Associated with Improved Survival in Node-Positive Merkel Cell Carcinoma: A National Cohort Analysis.|2021|Copeland AR,Shindorf ML,McDonald JD,Hernandez JM,Davis JL,|

ASO Author Reflections: False Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcin...
https://doi.org/10.1245/s10434-021-10056-4 10.1245/s10434-009-0858-x 10.1016/j.jaad.2019.12.072
Annals of Surgical Oncology; Straker RJ, Karakousis GC et. al.

Apr 29th, 2021 - ASO Author Reflections: False Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma.|2021|Straker RJ,Karakousis GC,Miura JT,|

see more →

News  165 results

Larger Surgical Margins Tied to Better Outcomes in Merkel Cell Carcinoma
https://www.medscape.com/viewarticle/948543

Apr 1st, 2021 - NEW YORK (Reuters Health) - In patients with localized Merkel cell carcinoma, larger local excision (LE) margins are associated with longer overall survival, as is the use of radiotherapy, according to a large new study. "The study demonstrates th...

Neoadjuvant Nivolumab 'Promising' in Merkel Cell Carcinoma
https://www.medscape.com/viewarticle/930115

May 6th, 2020 - Neoadjuvant nivolumab (Opdivo, Bristol-Myers Squibb) could improve outcomes for patients with high-risk resectable Merkel cell carcinoma (MCC), say researchers reporting the first trial in this patient population. The results come from a cohort of...

Merkel cell carcinoma management undergoes revolution
https://www.mdedge.com/hematology-oncology/article/218842/nonmelanoma-skin-cancer/merkel-cell-carcinoma-management/page/0/1?channel=39313

Mar 11th, 2020 - Immune therapy takes center stage Another major transformation in MCC management has been the emergence of immune therapy as first-line systemic therapy. It has replaced chemotherapy, which is more toxic and has a much shorter average duration of.

The Nine-Headed Monster: Recalcitrant Warts
https://www.medscape.com/viewarticle/924499_2

Feb 11th, 2020 - Viewpoint This retrospective histologic study found that lesional keratinocytes within warts express PD-L1 and the associated inflammatory infiltrate expresses PD-1. This is similar to what is seen in melanoma, Merkel cell carcinoma, and squamous ...

Serum test sheds light on Merkel cell carcinoma
https://www.mdedge.com/fedprac/article/212426/nonmelanoma-skin-cancer/serum-test-sheds-light-merkel-cell-carcinoma?channel=285
Randy Dotinga

Nov 15th, 2019 - LAS VEGAS – Merkel cell carcinoma, an extremely rare form of skin cancer, is often caused by a subclinical virus that routinely inhabits the skin. Now, a serum test of virus antibody levels is offering insight into the state of the disease, accord.

see more →

Patient Education  13 results see all →